Your session is about to expire
← Back to Search
Behavioral Intervention
Exercise Program for Endometrial Cancer Survivors
N/A
Recruiting
Research Sponsored by Jess S. Gorzelitz
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Completion of current cytotoxic treatment for endometrial cancer
* Women 18-74 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help women who have had endometrial cancer by providing a 12-week exercise program to improve their fitness and heart health. Participants will undergo various tests and will receive exercise equipment and
Who is the study for?
The STRIVE Cardio trial is for English-speaking women aged 18-74 who have been treated for non-metastatic Type I endometrial cancer stages I-IIIc within the last five years and are now in remission. They must be able to use technology for telecoaching, pass a physical activity readiness test, get medical clearance if needed, and commit to the study's duration.
What is being tested?
This study tests a 12-week home-based exercise program designed to improve fitness and heart health in endometrial cancer survivors. Participants will receive resistance bands, a dumbbell, and a Fitbit. Their fitness levels and cardiovascular health will be assessed before and after the intervention.
What are the potential side effects?
Since this is an exercise intervention trial, potential side effects may include muscle soreness or strain from physical activities. However, participants will undergo assessments to ensure they're ready for increased activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have finished my chemotherapy for endometrial cancer.
Select...
I am a woman aged between 18 and 74.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Vascular Stiffness Following Distance-Based Exercise Program
Secondary study objectives
Changes in Atherosclerotic Cardiovascular Disease (ASCVD) Risk Profiles Following a Distance-Based Exercise Program
Changes in Vascular Function Following Distance-Based Exercise Program
Other study objectives
Change in Waist to Hip ratio (WHR)
Changes in Ambulatory Activity Levels
Changes in Functional Fitness
+11 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 12-week Exercise InterventionExperimental Treatment1 Intervention
In this single-arm study, every participant will be enrolled in the 12-week distance-based exercise intervention. All participants will receive an exercise regimen and the necessary materials to complete and measure their exercise. All participants will receive weekly online heath coaching.
Find a Location
Who is running the clinical trial?
Jess S. GorzelitzLead Sponsor